Your browser doesn't support javascript.
loading
Real-world observational cohort study of treatment patterns and safety outcomes of infliximab biosimilar CT-P13 for the treatment of inflammatory bowel disease (CONNECT-IBD).
Bokemeyer, Bernd; Hlavaty, Tibor; Allez, Matthieu; Selema, Pamela; Moosavi, Shahrzad; Cadatal, Mary Jane; Fowler, Heather; Mueller, Markus; Liau, Katherine F; Gisbert, Javier P.
Afiliação
  • Bokemeyer B; Interdisciplinary Crohn Colitis Centre Minden, Minden, Germany.
  • Hlavaty T; 5th Department of Internal Medicine, Sub-department of Gastroenterology and Hepatology, University Hospital Bratislava and Comenius University, Bratislava, Slovakia.
  • Allez M; Gastroenterology Department, Hôpital Saint-Louis - APHP, INSERM U1160, Université De Paris, Paris, France.
  • Selema P; Worldwide Safety and Risk Management, Pfizer, Inc, New York City, NY, USA.
  • Moosavi S; Worldwide Safety and Risk Management, Pfizer, Inc, New York City, NY, USA.
  • Cadatal MJ; Global Biometrics and Data Management, Pfizer, Inc, Manila, Philippines.
  • Fowler H; Clinical Development and Operations, Pfizer, Inc, London, UK.
  • Mueller M; Medical Affairs, Pfizer, Pharma GmbH, Berlin, Germany.
  • Liau KF; Biosimilars, Pfizer, Inc, La Jolla, CA, USA.
  • Gisbert JP; Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
Expert Opin Biol Ther ; 23(8): 791-800, 2023.
Article em En | MEDLINE | ID: mdl-37038897

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa / Doença de Crohn / Medicamentos Biossimilares Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Expert Opin Biol Ther Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa / Doença de Crohn / Medicamentos Biossimilares Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Expert Opin Biol Ther Ano de publicação: 2023 Tipo de documento: Article